Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Braidy, Nady ^a   Selvaraju, Subash ^b   Essa, Musthafa Mohamed ^b   Vaishnav, Ragini ^b   Al Adawi, Samir ^b   Al Asmi, Abdullah ^b   Al Senawi, Hamed ^b   Abd Alrahman Alobaidy, Ammar ^b   Lakhtakia, Ritu ^b   Guillemin, Gilles J ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEGENERATIVE DISEASE; DOPAMINERGIC NEURONS; ENVIRONMENTAL TOXINS; GLUTATHIONE PEROXIDASE; NEUROPROTECTIVE EFFECTS; PARKINSON'S DISEASE; SUPEROXIDE DISMUTASES; THERAPEUTIC COMPOUNDS;

ENZYME ACTIVITY; LIPIDS; OXIDATIVE STRESS; OXYGEN; PEPTIDES; TOXICITY;

NEURONS;

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIOXIDANT; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; POMEGRANATE EXTRACT; SUPEROXIDE DISMUTASE; ADENOSINE TRIPHOSPHATE; NEUROPROTECTIVE AGENT; NEUROTOXIN; PHENOL DERIVATIVE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN NERVE CELL; DOSE RESPONSE; DRUG CYTOTOXICITY; ENZYME ACTIVITY; FETUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; POMEGRANATE JUICE; BEVERAGE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; LYTHRACEAE; METABOLISM; NERVE CELL; OMAN; PATHOLOGY; TOXICITY; DRUG EFFECT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANTS; BEVERAGES; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; HUMANS; LIPID PEROXIDATION; NAD; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OMAN; OXIDATIVE STRESS; PHENOLS; PLANT EXTRACTS; PUNICACEAE; REACTIVE OXYGEN SPECIES;

EID: 84886657375     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/685909     Document Type: Article

References (81)

1. Lo Bianco C., Schneider B. L., Bauer M., Sajadi A., Brice A., Iwatsubo T., Aebischer P., Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an α -synuclein rat model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2004 101 50 17510 17515 2-s2.0-10644281090 10.1073/pnas.0405313101 (Pubitemid 39657434)
2. Mandel S., Grünblatt E., Riederer P., Gerlach M., Levites Y., Youdim M. B. H., Neuroprotective strategies in Parkinson's disease: an update on progress. CNS Drugs 2003 17 10 729 762 2-s2.0-0041731997 10.2165/00023210- 200317100-00004 (Pubitemid 37000010)
3. Butterfield P. G., Environment: seeking clues to Parkinson's disease. Reflections 1996 22 3 14 15 2-s2.0-0030568023
4. Markesbery W. R., Neuropathological criteria for the diagnosis of Alzheimer's disease. Neurobiology of Aging 1997 18 supplement 4 S13 S19 2-s2.0-0030668223 10.1016/S0197-4580(97)00064-X (Pubitemid 27454691)
5. Ball M. J., Murdoch G. H., Neuropathological criteria for the diagnosis of Alzheimer's disease: are we really ready yet? Neurobiology of Aging 1997 18 supplement 4 S3 S12 2-s2.0-0030668020 10.1016/S0197-4580(97)00074-2 (Pubitemid 27454690)
6. Kumar H., Koppula S., Kim I. S., More S. V., Kim B. W., Choi D. K., Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death. CNS and Neurological Disorders 2012 11 8 1015 1029
7. Yan M. H., Wang X., Zhu X., Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radical Biology and Medicine 2013 62 90 101
8. Perfeito R., Cunha-Oliveira T., Rego A. C., Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Free Radical Biology and Medicine 2012 53 9 1791 1806
9. Jeong H. J., Kim D. W., Woo S. J., Kim H. R., Kim S. M., Jo H. S., Park M., Kim D., Kwon O., Hwang I. K., Han K. H., Park J., Eum W. S., Choi S. Y., Transduced Tat-DJ-1 protein protects against oxidative stress-induced SH-SY5Y cell death and Parkinson disease in a mouse model. Molecules and Cells 2012 33 5 471 478 2-s2.0-84859881994 10.1007/s10059-012-2255-8
10. Chien W., Lee T., Hung S., Kang K., Fu W., Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1. Journal of Neurochemistry 2011 117 4 643 653 2-s2.0-79955046650 10.1111/j.1471-4159.2011.07229.x
11. Bayir H., Kapralov A. A., Jiang J., Huang Z., Tyurina Y. Y., Tyurin V. A., Zhao Q., Belikova N. A., Vlasova I. I., Maeda A., Zhu J., Na H., Mastroberardino P., Sparvero L. J., Amoscato A. A., Chu C. T., Greenamyre J. T., Kagan V. E., Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome c. Protection against apoptosis versus delayed oxidative stress in Parkinson disease. The Journal of Biological Chemistry 2009 284 23 15951 15969 2-s2.0-67650156461 10.1074/jbc.M900418200
12. Henchcliffe C., Beal F. M., Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature Clinical Practice Neurology 2008 4 11 600 609 2-s2.0-55849122639 10.1038/ncpneuro0924
13. Bloomer R. J., Schilling B. K., Karlage R. E., Ledoux M. S., Pfeiffer R. F., Callegari J., Effect of resistance training on blood oxidative stress in Parkinson disease. Medicine and Science in Sports and Exercise 2008 40 8 1385 1389 2-s2.0-58149359464 10.1249/MSS.0b013e31816f1550
14. Nunomura A., Moreira P. I., Lee H. G., Zhu X., Castellani R. J., Smith M. A., Perry G., Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS and Neurological Disorders 2007 6 6 411 423 2-s2.0-41749088686 10.2174/187152707783399201 (Pubitemid 351486255)
15. Battisti C., Formichi P., Radi E., Federico A., Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation. Journal of the Neurological Sciences 2008 267 1-2 120 124 2-s2.0-39049097607 10.1016/j.jns.2007.10.012 (Pubitemid 351248914)
16. Yamamoto N., Sawada H., Izumi Y., Kume T., Katsuki H., Shimohama S., Akaike A., Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. The Journal of Biological Chemistry 2007 282 7 4364 4372 2-s2.0-33947517977 10.1074/jbc.M603712200 (Pubitemid 47101000)
17. Ebadi M., Sharma S., Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease. Experimental Biology and Medicine 2006 231 9 1576 1583 2-s2.0-33749610125 (Pubitemid 44547853)
18. Veech G. A., Dennis J., Keeney P. M., Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress. Journal of Neuroscience Research 2000 61 6 693 700
19. González-Fraguela M. E., Indicators of oxidative stress and the effect of antioxidant treatment in patients with primary Parkinson's disease. Revista de Neurologia 1998 26 149 28 33 2-s2.0-0031594709
20. Castellani R., Smith M. A., Richey P. L., Perry G., Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Research 1996 737 1-2 195 200 2-s2.0-0030597071 10.1016/0006-8993(96)00729-9 (Pubitemid 26366614)
21. Langston J. W., Ballard P. A. Jr., Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. The New England Journal of Medicine 1983 309 5 310 2-s2.0-0005444118 (Pubitemid 13074924)
22. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., Kopin I. J., A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proceedings of the National Academy of Sciences of the United States of America 1983 80 14 I 4546 4550 2-s2.0-0001496694 (Pubitemid 13077876)
23. Langston J. W., Ballard P., Parkinsonism induced by 1-methyl-4-phenyl-1, 2,5,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. Canadian Journal of Neurological Sciences 1984 11 supplement 1 160 165 2-s2.0-0021239393 (Pubitemid 14133460)
24. Crossman A. R., Peggs D., Boyce S., Luquin M. R., Sambrook M. A., Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey. Neuropharmacology 1989 28 11 1271 1273 2-s2.0-0024420232 (Pubitemid 19277043)
25. Chiba K., Trevor A., Castagnoli N. Jr., Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochemical and Biophysical Research Communications 1984 120 2 574 578 2-s2.0-0021276089 (Pubitemid 14101750)
26. Singer T. P., Castagnoli N. Jr., Ramsay R. R., Trevor A. J., Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Journal of Neurochemistry 1987 49 1 1 8 2-s2.0-0023224837 (Pubitemid 17108222)
27. Notter M. F. D., Irwin I., Langston J. W., Gash D. M., Neurotoxicity of MPTP and MPP+ in vitro: characterization using specific cell lines. Brain Research 1988 456 2 254 262 2-s2.0-0023706016
28. Langley P., Why a pomegranate? British Medical Journal 2000 321 7269 1153 1154 2-s2.0-0034605755
29. Vidal A., Fallarero A., Peña B. R., Medina M. E., Gra B., Rivera F., Gutierrez Y., Vuorela P. M., Studies on the toxicity of Punica granatum L. (Punicaceae) whole fruit extracts. Journal of Ethnopharmacology 2003 89 2-3 295 300 2-s2.0-0242721412 10.1016/j.jep.2003.09.001 (Pubitemid 37378206)
30. Aggarwal B. B., Shishodia S., Suppression of the nuclear factor- B activation pathway by spice-derived phytochemicals: reasoning for seasoning. Annals of the New York Academy of Sciences 2004 1030 434 441 2-s2.0-15044361086 10.1196/annals.1329.054 (Pubitemid 40378943)
31. Ashoori F., Suzuki S., Zhou J. H. Z., Isshiki N., Miyachi Y., Involvement of lipid peroxidation in necrosis of skin flaps and its suppression by ellagic acid. Plastic and Reconstructive Surgery 1994 94 7 1027 1037 2-s2.0-0028114723 (Pubitemid 24374617)
32. Hirose M., Hasegawa R., Kimura J., Akagi K., Yoshida Y., Tanaka H., Miki T., Satoh T., Wakabayashi K., Ito N., Shirai T., Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d] (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Carcinogenesis 1995 16 12 3049 3055 2-s2.0-0029616654
33. Kim N. D., Mehta R., Yu W., Neeman I., Livney T., Amichay A., Poirier D., Nicholls P., Kirby A., Jiang W., Mansel R., Ramachandran C., Rabi T., Kaplan B., Lansky E., Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Research and Treatment 2002 71 3 203 217 2-s2.0-0036201937 10.1023/A:1014405730585 (Pubitemid 34263985)
34. Gil M. I., Tomas-Barberan F. A., Hess-Pierce B., Holcroft D. M., Kader A. A., Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. Journal of Agricultural and Food Chemistry 2000 48 10 4581 4589 2-s2.0-0033788223 10.1021/jf000404a
35. Aviram M., Pomegranate juice as a major source for polyphenolic flavonoids and it is most potent antioxidant against LDL oxidation and atherosclerosis. Proceedings of the 11th Biennial Meeting of the Society for Free Radical Research International July 2002 523 528
36. Aviram M., Pomegranate juice as a major source for polyphenolic flavonoids and it is most potent antioxidant against LDL oxidation and atherosclerosis. Free Radical Biology and Medicine 2002 33 S139 S140
37. Aviram M., Rosenblat M., Gaitini D., Nitecki S., Hoffman A., Dornfeld L., Volkova N., Presser D., Attias J., Liker H., Hayek T., Corrigendum to: pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation, Clinical Nutrition, vol. 23, pp. 423-433, 2004. Clinical Nutrition 2008 27 4 671 2-s2.0-49949116696 10.1016/j.clnu.2008.05.001
38. Bandeira Sde M., Bandeira Sde M., Guedes Gda S., da Fonseca L. J., Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxidative Medicine and Cellular Longevity 2012 2012 13 819310 10.1155/2012/819310
39. Butterfield A., Swomley A. M., Sultana R., Amyloid β -peptide (1-42)-induced oxidative stress in alzheimer disease: importance in disease pathogenesis and progression. Antioxidants and Redox Signaling 2012 19 8 823 835
40. Mori-Okamoto J., Otawara-Hamamoto Y., Yamato H., Yoshimura H., Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariectomized mice. Journal of Ethnopharmacology 2004 92 1 93 101 2-s2.0-1942487864 10.1016/j.jep.2004.02.006 (Pubitemid 38510269)
41. Rosenblat M., Aviram M., Antioxidants as targeted therapy: a special protective role for pomegranate and paraoxonases (PONs). Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment 2010 New Jersey, NJ, USA Humana Press 621 634
42. Rosenblat M., Hayek T., Aviram M., Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis 2006 187 2 363 371 2-s2.0-33745495836 10.1016/j.atherosclerosis. 2005.09.006 (Pubitemid 43963016)
43. Rosenblat M., Volkova N., Aviram M., Pomegranate juice (PJ) consumption antioxidative properties on mouse macrophages, but not PJ beneficial effects on macrophage cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation of macrophage PON2. Atherosclerosis 2010 212 1 86 92 2-s2.0-77956231001 10.1016/j.atherosclerosis.2010.04.039
44. Sagar V. R., Kumar P. S., Recent advances in drying and dehydration of fruits and vegetables: a review. Journal of Food Science and Technology 2010 47 1 15 26 2-s2.0-77955097824 10.1007/s13197-010-0010-8
45. Bchir B., Besbes S., Attia H., Blecker C., Osmotic dehydration of pomegranate seeds (Punica granatum l.): effect of freezing pre-treatment. Journal of Food Process Engineering 2012 35 3 335 354
46. Berker K. I., Olgun F. A. O., Ozyurt D., Modified Folin-Ciocalteu antioxidant capacity assay for measuring lipophilic antioxidants. Journal of Agricultural and Food Chemistry 2013 61 20 4783 4791
47. Guillemin G. J., Smythe G., Takikawa O., Brew B. J., Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 2005 49 1 15 23 2-s2.0-11144314849 10.1002/glia.20090 (Pubitemid 40023649)
48. Guillemin G. J., Cullen K. M., Lim C. K., Smythe G. A., Garner B., Kapoor V., Takikawa O., Brew B. J., Characterization of the kynurenine pathway in human neurons. Journal of Neuroscience 2007 27 47 12884 12892 2-s2.0-36448939072 10.1523/JNEUROSCI.4101-07.2007 (Pubitemid 350161746)
49. Bernofsky C., Swan M., An improved cycling assay for nicotinamide adenine dinucleotide. Analytical Biochemistry 1973 53 2 452 458 2-s2.0-0015888084
50. Grant R. S., Kapoor V., Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates. Journal of Neurochemistry 1998 70 4 1759 1763 2-s2.0-0031930117 (Pubitemid 28136993)
51. Koh J. Y., Choi D. W., Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. Journal of Neuroscience Methods 1987 20 1 83 90 2-s2.0-0023221068 (Pubitemid 17062742)
52. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976 53 452 458 2-s2.0-0017184389
53. Cordesse V., Jametal T., Guy C., Analysis of clinical pathway in changing and disabling neurological diseases. Revue Neurologique 2013 169 6-7 476 484
54. Houghton P. J., Howes M., Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease. NeuroSignals 2005 14 1-2 6 22 2-s2.0-20944441667 10.1159/000085382 (Pubitemid 40868980)
55. Mythri R. B., Harish G., Bharath M. M., Therapeutic potential of natural products in Parkinson's disease. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery 2012 6 3 181 200
56. Hartman R. E., Shah A., Fagan A. M., Schwetye K. E., Parsadanian M., Schulman R. N., Finn M. B., Holtzman D. M., Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiology of Disease 2006 24 3 506 515 2-s2.0-33750807197 10.1016/j.nbd.2006.08.006 (Pubitemid 44716679)
57. Markey S. P., Johannessen J. N., Chiueh C. C., Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 1984 311 5985 464 467 2-s2.0-0021137683
58. Ho P. W., Ho W. Je., Liu L., Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease. Translational Neurodegeneration 2012 1 1, article 3
59. Kutty R. K., Santostasi G., Horng J., Krishna G., MPTP-induced ATP depletion and cell death in neuroblastoma X glioma hybrid NG 108-15 cells: protection by glucose and sensitization by tetraphenylborate. Toxicology and Applied Pharmacology 1991 107 2 377 388 2-s2.0-0025966995 10.1016/0041-008X(91) 90217-3
60. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A., Biomarkers of oxidative damage in human disease. Clinical Chemistry 2006 52 4 601 623 2-s2.0-33645459044 10.1373/clinchem.2005.061408
61. Shulaev V., Oliver D. J., Metabolic and proteomic markers for oxidative stress. New tools for reactive oxygen species research. Plant Physiology 2006 141 2 367 372 2-s2.0-33745674718 10.1104/pp.106.077925 (Pubitemid 43974529)
62. Thiffault C., Aumont N., Quirion R., Poirier J., Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. Journal of Neurochemistry 1995 65 6 2725 2733 2-s2.0-0028971624 (Pubitemid 3002930)
63. .- radical dot-production rates differentially regulate oxidative, nitroxidative, and nitrosative stress in the microcirculation. Free Radical Biology and Medicine 2013 63 161 174 10.1016/j.freeradbiomed.2013.04.024
64. Ribeiro L. C., Rodrigues L., Quincozes-Santos A., Caloric restriction improves basal redox parameters in hippocampus and cerebral cortex of Wistar rats. Brain Research 2012 1472 11 19
65. Dokic I., Hartmann C., Herold-Mende C., Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress. Glia 2012 60 11 1785 1800
66. Esposito L. A., Kokoszka J. E., Waymire K. G., Cottrell B., MacGregor G. R., Wallace D. C., Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. Free Radical Biology and Medicine 2000 28 5 754 766 2-s2.0-0034062554 10.1016/S0891-5849(00)00161-1 (Pubitemid 30171289)
67. Inoue Y., Tran L., Kamakura M., Izawa S., Miki T., Tsujimoto Y., Kimura A., Oxidative stress response in yeast: glutathione peroxidase of Hansenula mrakii is bound to the membrane of both mitochondria and cytoplasm. Biochimica et Biophysica Acta 1995 1245 3 325 330 2-s2.0-0028876302 10.1016/0304-4165(95) 00117-4
68. Doroshow J. H., Glutathione peroxidase and oxidative stress. Toxicology Letters 1995 82-83 395 398 2-s2.0-0029557283 10.1016/0378-4274(95)03570-2 (Pubitemid 26054725)
69. Hom D. G., Jiang D., Hong E., Mo J. Q., Andersen J. K., Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity. Molecular Brain Research 1997 46 1-2 154 160 2-s2.0-0342872019 10.1016/S0169-328X(96)00296-3 (Pubitemid 27214366)
70. Drechsel D. A., Liang L., Patel M., 1-methyl-4-phenylpyridinium-induced alterations of glutathione status in immortalized rat dopaminergic neurons. Toxicology and Applied Pharmacology 2007 220 3 341 348 2-s2.0-34247269064 10.1016/j.taap.2007.02.002 (Pubitemid 46627847)
71. Hirrlinger J., Gutterer J. M., Kussmaul L., Hamprecht B., Dringen R., Microglial cells in culture express a prominent glutathione system for the defense against reactive oxygen species. Developmental Neuroscience 2000 22 5-6 384 392 2-s2.0-0033668131 10.1159/000017464
72. Hirrlinger J., Hamprecht B., Dringen R., Application and modulation of a permanent hydrogen peroxide-induced oxidative stress to cultured astroglial cells. Brain Research Protocols 1999 4 2 223 229 2-s2.0-0032861181 10.1016/S1385-299X(99)00023-9 (Pubitemid 29396423)
73. Croitoru-Lamoury J., Guillemin G. J., Boussin F. D., Mognetti B., Gigout L. I., Chéret A., Vaslin B., Le Grand R., Brew B. J., Dormont D., Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF α and IFN γ in CXCR4 and CCR5 modulation. Glia 2003 41 4 354 370 2-s2.0-0344321889 10.1002/glia.10181 (Pubitemid 36314149)
74. Guillemin G. J., Croitoru-Lamoury J., Dormont D., Armati P. J., Brew B. J., Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia 2003 41 4 371 381 2-s2.0-0037337196 10.1002/glia.10175 (Pubitemid 36314150)
75. Panickar K. S., Jang S., Dietary and plant polyphenols exert neuroprotective effects and improve cognitive function in cerebral ischemia. Recent Patents on Food, Nutrition and Agriculture 2013 5 2 128 143
76. Panickar K. S., Bioactive components of plant products including polyphenols exert neuroprotective effects and benefit neural function. Central Nervous System Agents in Medicinal Chemistry 2013 13 1, article 2
77. Tavares L., Figueira I., McDougall G. J., Neuroprotective effects of digested polyphenols from wild blackberry species. European Journal of Nutrition 2013 52 1 225 236
78. Essa M. M., Vijayan R. K., Castellano-Gonzalez G., Neuroprotective effect of natural products against Alzheimer's disease. Neurochemical Research 2012 37 9 1829 1842
79. Petti S., Scully C., Polyphenols, oral health and disease: a review. Journal of Dentistry 2009 37 6 413 423 2-s2.0-64549093700 10.1016/j.jdent.2009. 02.003
80. Seeram N. P., Zhang Y., McKeever R., Henning S. M., Lee R., Suchard M. A., Li Z., Chen S., Thames G., Zerlin A., Nguyen M., Wang D., Dreher M., Heber D., Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. Journal of Medicinal Food 2008 11 2 390 394 2-s2.0-46749097580 10.1089/jmf.2007.650 (Pubitemid 351948184)
81. Basu A., Penugonda K., Pomegranate juice: a heart-healthy fruit juice. Nutrition Reviews 2009 67 1 49 56 2-s2.0-64049109979 10.1111/j.1753-4887.2008. 00133.x